Bastide Le Confort Medical annual shareholders’ equity
2021
2022
2023
2024
2025
Bastide Le Confort Medical Shareholders’ Equity Growth & History (BLC)
Bastide Le Confort Medical's shareholders’ equity was €72.1M for fiscal 2025.
View full Bastide Le Confort Medical company overviewBastide Le Confort Medical annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | €72.1M | −€7.6M | −9.58% |
| 2024 | 2024-06-30 | €79.8M | −€7.9M | −8.99% |
| 2023 | 2023-06-30 | €87.6M | €3.1M | +3.65% |
| 2022 | 2022-06-30 | €84.6M | €3.3M | +4.00% |
| 2021 | 2021-06-30 | €81.3M | — | — |
Bastide Le Confort Medical quarterly shareholders’ equity
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | €102.7M | €26.7M | +35.05% |
| Q4 2025 | 2025-06-30 | €72.1M | — | — |
| Q2 2025 | 2024-12-31 | €76.1M | — | — |
Bastide Le Confort Medical shareholders’ equity trends
Between the periods ended 2021-06-30 and 2025-06-30, Bastide Le Confort Medical's shareholders’ equity decreased from €81.3M to €72.1M, a change of −€9.2M. The latest reported quarter, Q2 2026, shows €102.7M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bastide Le Confort Medical source filings ↗